-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's After-Market Session
Share
Listen to the news

Gainers

  • Agape ATP (NASDAQ:ATPC) stock increased by 8.0% to $4.47 during Monday's after-market session. The market value of their outstanding shares is at $4.8 million.
  • Cosmos Health (NASDAQ:COSM) shares increased by 6.21% to $0.27. The market value of their outstanding shares is at $13.4 million.
  • Aditxt (NASDAQ:ADTX) shares rose 6.19% to $0.12.
  • Quantum BioPharma (NASDAQ:QNTM) stock increased by 5.71% to $5.55. The company's market cap stands at $43.8 million.
  • Rein Therapeutics (NASDAQ:RNTX) stock rose 5.6% to $1.13. The company's market cap stands at $94.9 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) shares moved upwards by 5.47% to $5.78. The market value of their outstanding shares is at $4.8 million.

Losers

  • Fulcrum Therapeutics (NASDAQ:FULC) stock declined by 48.8% to $3.29 during Monday's after-market session. The company's market cap stands at $461.1 million.
  • Abivax (NASDAQ:ABVX) shares fell 21.73% to $101.51. The market value of their outstanding shares is at $10.5 billion.
  • Heron Therapeutics (NASDAQ:HRTX) shares fell 15.39% to $0.7. The company's market cap stands at $164.6 million.
  • Clearmind Medicine (NASDAQ:CMND) shares fell 8.52% to $2.9. The company's market cap stands at $3.6 million.
  • Tyra Biosciences (NASDAQ:TYRA) shares decreased by 7.87% to $28.0. The market value of their outstanding shares is at $1.9 billion.
  • Praxis Precision Medicine (NASDAQ:PRAX) shares declined by 7.51% to $310.0. The market value of their outstanding shares is at $9.7 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending